SeaWorld Makes A Big Splash In Worst Company Competition Debut; AT&T, Citi Also Move On

SeaWorld Makes A Big Splash In Worst Company Competition Debut; AT&T, Citi Also Move On

In the nearly decade-long history of Worst Company In America, we’ve noticed that newcomers — especially those who make the bracket because they’re in the news a lot — either flame out in the early rounds (like Lululemon) or take the tournament by storm (like past winners EA and BP). This year’s out-of-nowhere surprise comes courtesy of the folks at SeaWorld, which swam to an easy win in its WCIA debut. [More]

Formaldehyde In Baby Shampoo Isn’t As Scary As It Sounds

Formaldehyde In Baby Shampoo Isn’t As Scary As It Sounds

Recently, Johnson & Johnson reformulated their classic yellow baby shampoo after a consumer outcry over a scary-sounding formaldehyde-based preservative in the product. If it’s not absolutely necessary, there’s no good reason to go slathering a product that contains unnecessary substances on infants. The important question is: should we be worried about formaldehyde in personal-care products at all? [More]

Johnson & Johnson Reformulates Shampoo, Because Babies Don’t Need Formaldehyde In Their Baths

Johnson & Johnson Reformulates Shampoo, Because Babies Don’t Need Formaldehyde In Their Baths

If you asked most folks if formaldeyde sounds like a great ingredient for baby shampoo, they’d say “no.” And possibly also, “ew, gross.” Baby-goods behemoth Johnson & Johnson agrees that formaldehyde is not so much a thing your baby needs, and has rinsed it right out of their iconic yellow shampoo. [More]

Johnson & Johnson To Pay $2.2 Billion To Settle Deceptive Marketing Claims

Johnson & Johnson To Pay $2.2 Billion To Settle Deceptive Marketing Claims

For nearly a decade, various state and federal agencies have been looking into Johnson & Johnson’s marketing of the drugs Risperdal, Invega, Natrecor, and others, claiming the company was putting consumers at risk by paying kickbacks to doctors and pharmacists to suggest these drugs to patients and for pushing unapproved uses for these medications. Today, the Justice Dept. announced that J&J will pay out more than $2.2 billion to settle these claims. [More]

Children Died Because Johnson & Johnson Insisted On Selling Two Types Of Kids’ Tylenol

Children Died Because Johnson & Johnson Insisted On Selling Two Types Of Kids’ Tylenol

At the intersection of bad marketing, inept regulation, and unwitting consumers, you’ll find the graves of young children, just some of the infants who, according to a new report from ProPublica, have become ill over the decades because Johnson & Johnson and other makers of acetaminophen-based painkillers insisted on selling two youth-targeted varieties of the drug while the FDA did what it does best — nothing. [More]

The new Tylenol caps.

Johnson & Johnson Reveals New Acetaminophen Warning Labels On Bottles Of Tylenol

Johnson & Johnson has revealed a new bottle cap design for Tylenol products sold in the U.S. which will warn consumers in bright red lettering that the medication contains acetaminophen. The labels will alert users to the potentially fatal risks of taking too much Tylenol, which is an unusual step for a company to make. [More]

(SA_Steve)

Lawsuit Accuses Big Pharma Of Using Bogus Expiration Dates To Trick Customers Into Buying More Meds

When it comes to over-the-counter pain pills, many people don’t even think to look at the expiration date on the side of the bottle. But a new class-action lawsuit claims that three of the biggest names in the (legal) drug business are deliberately putting early expiration dates on their products to encourage customers to throw them out and buy new ones. [More]

Johnson & Johnson Promises To Kick All Harsh Chemicals To The Curb By End Of 2015

Johnson & Johnson Promises To Kick All Harsh Chemicals To The Curb By End Of 2015

Johnson & Johnson is going forward with plans to take out any of the nasty chemicals consumers have taken issue with recently, by pledging not only to remove “chemicals of concern” from baby products by 2013, but also to reformulate adult products with safer ingredients by the end of 2015. [More]

How I Took On Johnson & Johnson In Small Claims Court, And Won

How I Took On Johnson & Johnson In Small Claims Court, And Won

Desitin, the diaper rash treatment, is not a nice-smelling substance. Joyce’s husband, Ben, could tell that much before using it to treat the aftereffects of some severe gastrointestinal distress. What he didn’t realize was that the unholy stench could not be defeated. It soaked through his clothing, and when he tried to launder those clothes, the smell didn’t go away: it spread to those other items as well. Annoyed at having to toss $600 worth of clothing, the couple contacted Johnson & Johnson, seeking compensation and encouraging the company to do more to deter people who do not currently wear disposable diapers from using the product. After some letters and an offer of $75 passed in the mail, they went to small claims court. And won. [More]

Court Orders Johnson & Johnson To Pay $1.2 Billion In Deceptive Marketing Case

Court Orders Johnson & Johnson To Pay $1.2 Billion In Deceptive Marketing Case

Johnson & Johnson and a subsidiary have to pay for the way it marketed antipsychotic drug Risperdal, neglecting to mention its side effects while claiming it was safer and worked better than the competition. In Arkansas, one of 11 states in which J&J has faced legal battles over the drug, a judge ordered the company to pay $1.2 billion to make up for its alleged sins. [More]

Johnson & Johnson Ends 2011 Just At It Began — By Recalling More Stuff

Johnson & Johnson Ends 2011 Just At It Began — By Recalling More Stuff

After more than a year of near-constant recalls, the folks at Johnson & Johnson’s McNeil Labs aren’t finished yet. This time, it’s a mere 12 million bottles of Motrin that are being recalled from store shelves because the pills may not dissolve as quickly as they are supposed to. [More]

O.B. Finally Apologizes To America For Tampon Shortage (With A Catch)

O.B. Finally Apologizes To America For Tampon Shortage (With A Catch)

Last week, we told you the folks at o.b. tampons had issued an oddball, tongue-in-cheek apology in the form of a cheeseball ballad, complete with customizable video, for the many months that their products were off store shelves. Only problem was, that apology — and the coupon that came with it — was only available to Canadian shoppers. [More]

O.B. Tampons Apologizes To Canadian Customers… In Song Form

O.B. Tampons Apologizes To Canadian Customers… In Song Form

As many of you may remember from this time last year, o.b. tampons became one of many Johnson & Johnson products to disappear from store shelves. And for many, many months, store shelves remained o.b.-free, until they gradually began showing up in the spring. Now the tampon makers are saying “we’re sorry”… at least to its Canadian customers. [More]

Exxon Mobil Is The Most Profitable American Business By A Long Shot

Exxon Mobil Is The Most Profitable American Business By A Long Shot

This year’s Fortune 500 list is out, and while Walmart’s $421 billion in revenue may have beaten out Exxon Mobil’s paltry $354 billion, the oil giant beat out Big W where it matters most, profits. According to Fortune, the crude colossus made a whopping $30.4 billion in profits last year, nearly double what Walmart made and over $10.5 billion more than the next most profitable company on the list. [More]

Johnson & Johnson's Prescription Drugs Stink Too: 57,000 Bottles Of Topamax Recalled

Johnson & Johnson's Prescription Drugs Stink Too: 57,000 Bottles Of Topamax Recalled

If you thought Johnson & Johnson’s McNeil Labs division — the folks behind all of these recalled over-the-counter drugs — was the only branch of the company capable of creating stinky meds, you were wrong, as J&J has announced a recall of two lots of its prescription anitconvulsant Topamax for that now-classic “uncharacteristic odor.” [More]

Johnson & Johnson Settles With SEC & DOJ For $70 Million For Bribing Doctors Overseas, Paying Kickbacks To Iraq

Johnson & Johnson Settles With SEC & DOJ For $70 Million For Bribing Doctors Overseas, Paying Kickbacks To Iraq

Johnson & Johnson may have been eliminated from the Worst Company In America tournament, but the company’s craptastic year continues, as J&J has settled with the Securities and Exchange Commission and Dept. of Justice over allegations that it violated the Foreign Corrupt Practices Act by illegally bribing doctors in Europe and paying kickbacks to Iraq… At least it wasn’t another product recall. [More]

Worst Company In America Sweet 16: Johnson & Johnson Vs. WellPoint

Worst Company In America Sweet 16: Johnson & Johnson Vs. WellPoint

In honor of April 1, we present this WCIA faceoff between a pair of fools — One that makes medicines no one can sell and the other that takes your insurance premium but offers you no insurance. [More]

Johnson & Johnson Keeps The Tylenol Recall Express Rolling

Johnson & Johnson Keeps The Tylenol Recall Express Rolling

In advance of its Worst Company In America Sweet 16 bout against WellPoint, Johnson & Johnson has given us all a reminder of why they made the list to begin with, announcing yet another recall of a Tylenol product. [More]